Tim De Smedt
UCB Pharma (Belgium)(BE)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies, EEG and Brain-Computer Interfaces, Neurological disorders and treatments
Most-Cited Works
- → Deep Brain Stimulation in Patients with Refractory Temporal Lobe Epilepsy(2007)370 cited
- → Nanobodies® † †Nanobody is a registered trademark of Ablynx NV. as inhaled biotherapeutics for lung diseases(2016)178 cited
- → Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective(2022)110 cited
- → Levetiracetam: Part II, the Clinical Profile of a Novel Anticonvulsant Drug(2007)102 cited
- → Seizures in the intrahippocampal kainic acid epilepsy model: characterization using long-term video-EEG monitoring in the rat(2008)95 cited
- → Levetiracetam: The Profile of a Novel Anticonvulsant Drug—Part I: Preclinical Data(2007)76 cited
- → High Frequency Deep Brain Stimulation in the Hippocampus Modifies Seizure Characteristics in Kindled Rats(2007)66 cited
- Neurostimulation for refractory epilepsy.(2003)
- → Radiation of the Rat Brain Suppresses Seizure‐Induced Neurogenesis and Transiently Enhances Excitability during Kindling Acquisition(2007)43 cited
- → Modulation of Gut-Associated Lymphoid Tissue Functions with Genetically ModifiedLactococcus lactis(2009)28 cited